Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Epoprostenol for Injection in Patients With Pulmonary Arterial Hypertension (Epitome2ext)

This study has been completed.
Information provided by (Responsible Party):
Actelion Identifier:
First received: October 28, 2011
Last updated: December 14, 2015
Last verified: December 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2015
  Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)